Researchers from Sungkyunkwan University School of Medicine Detail Findings in Metastatic Breast Cancer (Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or ...)

Media coverage

• Title	Researchers from Sungkyunkwan University School of Medicine Detail Findings in Metastatic Breast Cancer (Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or ...)
  Media name/outlet	NewsRx Women's Health Daily
  Country/Territory	United States
  Date	26.07.16
  Persons	Han-Jung Chae, Sul Ki Park